Retatrutide 20mg

Retatrutide 20mg — Research Peptide

LAB 101 Retatrutide 20mg is a research peptide supplied for laboratory and scientific research applications. Retatrutide is an investigational triple receptor agonist studied for its activity at the GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. Current scientific research is investigating these pathways in areas including energy metabolism, appetite regulation, glucose metabolism, body weight and metabolic health.

For researchers looking for Retatrutide in Australia, LAB 101 Retatrutide 20mg is supplied in lyophilised form with a focus on product transparency, consistency and batch documentation. All peptides are independently verified at ≥99% purity. 

Product: Retatrutide
Quantity: 20mg per vial
Form: Lyophilised powder
Research areas: GLP-1/GIP/glucagon receptor signalling, metabolic research, energy expenditure, appetite regulation and weight-management research
Location: Australia

Research Use Only: This product is supplied strictly for laboratory and scientific research purposes. It is not intended for human consumption, therapeutic use, injection or self-administration.